Professor of Medicine at University of Utah

Nephrology

Martin Gregory is an expert in the field of Nephrology. He received 2 awards: "Regional Top Doctor" and "Top MD". Martin Gregory is a published physician as well. He has 40 publications published. The latest was: Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients with X-linked Alport syndrome.

Publications

---

• Clinical practice recommendations for the treatment of Alport Syndrome: a statement of the Alport Syndrome Research Collaborative.
• Genotype-phenotype correlation in X-linked Alport Syndrome.
• Cost-effective dialysis for the developing world.
• Distribution of type IV collagen in the cochlea in Alport Syndrome.
• The clinical features of thin basement membrane Nephropathy.
• Temporal bone histopathology in alport Syndrome.
• Alport syndrome and thin basement membrane Nephropathy: unraveling the tangled strands of type IV collagen.
• Reification of abstract concepts to improve comprehension using interactive virtual environments and a knowledge-based design: a Renal physiology model.
• High-density genetic and physical mapping of DNA markers near the X-linked Alport Syndrome locus: definition and use of flanking polymorphic markers.
• Expression of mRNA for type IV collagen alpha1, alpha5 and alpha6 chains by cultured dermal fibroblasts from patients With X-linked Alport syndrome.
• Identification of variant Alport phenotypes using an Alport-specific antibody probe.
• Molecular testing for adult type Alport Syndrome.
• Mutations in the codon for a conserved arginine-1563 in the COL4A5 collagen gene in Alport Syndrome.
• Identification of mutations in the COL4A5 collagen gene in Alport Syndrome.
• A mutation causing Alport syndrome With tardive hearing loss is common in the western United States.
• Alport Syndrome--clinical phenotypes, incidence, and pathology.
• Stem cell therapy for Alport Syndrome: the hope beyond the hype.
• Efficient detection of Alport syndrome COL4A5 mutations With multiplex genomic PCR-SSCP.
• Application of linked markers for genetic diagnosis of Alport Syndrome.
• A prospective study on treatment of hypercholesterolemia With lovastatin in renal transplant patients receiving cyclosporine.
• Single base mutation in alpha 5(IV) collagen chain gene converting a conserved cysteine to serine in Alport Syndrome.
• A preventable endemic condition.
• Type of hemodialysis and preference for behavioral involvement: interactive effects on adherence in end-stage renal Disease.
• Percutaneous native renal biopsy: comparison of a 1.2-mm spring-driven system With a traditional 2-mm hand-driven system.
• Common ancestry of three Ashkenazi-American families With Alport syndrome and COL4A5 R1677Q.
• Family support, physical impairment, and adherence in hemodialysis: an investigation of main and buffering effects.
• Prescribing hemodialysis using a weekly urea mass balance model.
• Health locus of control and depression in end-stage renal Disease.
• Cost of Hypertension treatment.
• Teaching behavior change skills to first-year medical students: a small group experiential approach.
• Eosinophilic fasciitis occurring four weeks after the onset of dialysis in a renal Failure patient.
• Amyloidosis and Reiter's Syndrome: report of a case and review of the literature.
• Alport Syndrome: clinical update.
• SIR 2004 film panel case: Primary hyperoxaluria type I mimicking arterial vasculitis--a lethal Disease.
• Ruptured sinus of Valsalva aneurysm in a patient with autosomal dominant polycystic Kidney disease.
• Home-based Renal dialysis.
• Renal deposition of cytomegalovirus antigen in immunoglobulin-A nephropathy.
• Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner, Sebastian, Epstein, and Al...
• Hearing loss.

Schools

---

• University Of Oxford Medical School Office

• Radcliff Infirm

• Churchill Hospital

• Hammersmith Hospital

• Hospital Necker

Procedures Preformed

---

• Hemodialysis
• Peritoneal Dialysis

Conditions Treated

---

• Acidosis
• Acute Kidney Failure
• Alkalosis
• Calcium Metabolism Disorders
• View All

Doctors Specialties

---

• Nephrology

Accepted Insurances

---

Awards

---

• Regional Top Doctor
• Top MD

Hospital

---

• University of Utah Health Care - Hospital and Clinics

Drug Facts

---

NPI NUMBER		1912926049
NPPES Provider LastName		GREGORY
NPPES Provider FirstName		MARTIN
NPPES Provider ZIPCode		841322412
NPPES Provider State		UT
Specialty Description		Nephrology
Total Claim Count		368.0
Distinct Opioid Count		0.0
Opioid Claim Count		0.0
Percent Opioid Claims		0.0

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1912926049
Last Name Of The Provider	GREGORY
First Name Of The Provider	MARTIN
View All

Similar Doctors

---

	Dr. Arasu Gopinath, MD This Doctor is OpenDoctor Recommended.
	Dr. Vijaykumar Lingegowda, MD This Doctor is OpenDoctor Recommended.
	Dr. Wayne A. Border, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Alfred K. Cheung, MD This Doctor is OpenDoctor Recommended. This doctor has more publications
	Dr. Richard G. Lambert, MD
	Dr. Kalani L. Raphael, MD This Doctor is OpenDoctor Recommended.
	Dr. Ruth M. Indahyung, MD This Doctor is OpenDoctor Recommended.
	Dr. James B. Stinson, MD This Doctor is OpenDoctor Recommended.
	Dr. Josephine D. Abraham, MD This Doctor is OpenDoctor Recommended.
	Dr. Sanjiv Anand, MD This Doctor is OpenDoctor Recommended.
	Dr. Amanda K. Hall, DO
	Tahir A. Zaman
	Dr. Harry O. Senekjian, MD This Doctor is OpenDoctor Recommended. This doctor has more publications

---

Doctor Directory | TOS | twitter | FB | Angel | blog